Clinical response to oral tofacitinib in pediatric patients with alopecia areata

Soundos Youssef; Lindsey A Bordone

doi:10.1016/j.jdcr.2022.08.024

Clinical response to oral tofacitinib in pediatric patients with alopecia areata

JAAD Case Rep. 2022 Aug 23:31:83-88. doi: 10.1016/j.jdcr.2022.08.024. eCollection 2023 Jan.

Authors

Soundos Youssef¹, Lindsey A Bordone²

Affiliations

¹ Postdoctoral Research Fellow, Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
² Department of Dermatology, Columbia University Irving Medical Center, New York, New York.

No abstract available

Keywords: AA, alopecia areata; AM, ante meridiem; AT, alopecia totalis; AU, alopecia universalis; Fig, Figure; ILS, intralesional steroid; JAK inhibitor; JAKi, Januse kinase inhibitor; Janus kinase inhibitor; PM, post meridiem; SALT, Severity of Alopecia Tool; alopecia areata; oral tofacitinib; pediatric population; treatment efficacy.

Publication types

Case Reports